Guodong Shen

5PUBLICATIONS
0CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Quantity surveying
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 13, 2025
A humanized anti-MSLN×4-1BB bispecific antibody exhibits potent antitumour activity through 4-1BB signaling activation and fc function without systemic toxicity.

Da-Yan Zhang, Zhi-Hua Zhang, Wen-Ting Liu

|May 31, 2023
An Fc-muted bispecific antibody targeting PD-L1 and 4-1BB induces antitumor immune activity in colorectal cancer without systemic toxicity.

Lian-Sheng Cheng, Min Zhu, Yan Gao

|Sep 08, 2022
A humanized 4-1BB-targeting agonistic antibody exerts potent antitumor activity in colorectal cancer without systemic toxicity.

Lian-Sheng Cheng, Yong-Feng Cheng, Wen-Ting Liu

|May 28, 2022
Cross-Sectional Associations between Living and Built Environments and Depression Symptoms among Chinese Older Adults.

Fangfang Hou, Xiao Han, Qiong Wang

|Feb 23, 2016
Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy.

Jia-Hui Xu, Shi-Lian Hu, Guo-Dong Shen

Pageof 1

Frequent Collaborators